Expert And 'Worthlessness Theory' Ejected In Valsartan MDL

By Jonathan Capriel · April 8, 2025, 8:45 PM EDT

Patients and insurers who claim they were ripped off when purchasing the contaminated blood pressure medication Valsartan won't be able to argue that the drug was worthless as a matter of...

To view the full article, register now.

Documents

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

1:19-md-02875

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019